Compare Indivior Pharmaceuticals Inc. Common Stock (INDV) vs Jabil Inc (JBL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Indivior Pharmaceuticals Inc. Common Stock vs Jabil Inc — how do they compare? Indivior Pharmaceuticals Inc. Common Stock trades at $34.6 (market cap $4.03B), while Jabil Inc trades at $286.2 (market cap $30.80B). The key difference: Jabil Inc is far larger — about 7.6× Indivior Pharmaceuticals Inc. Common Stock's market cap, and Jabil Inc pays a 0.11% dividend while Indivior Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Indivior Pharmaceuticals Inc. Common Stock for 0 Days and Jabil Inc for 24 Days on average.
| INDV | JBL | |
|---|---|---|
Market Cap | $4.03B | $30.80B |
Volume | 2,781,171 | 1,484,579 |
Sector | Health | Technology |
52-Week High | $41.83 | $385.50 |
52-Week Low | $24.09 | $192.49 |
Typical Hold Time | 0 Days | 24 Days |
Enterprise Value | $4.32B | $33.08B |
Dividend Yield | — | 0.11% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
JBL trades at $317.86, up 1.87% with strong technical momentum and bullish moving average signals. The company delivered three consecutive earnings beats, with Q2 2026 EPS of $4.40 exceeding expectations. Revenue growth is accelerating, driven by AI infrastructure demand, with fiscal 2027 guidance projecting 24% growth. Analyst consensus remains strongly bullish with a $434.75 price target representing 37% upside potential.
The outlook for JBL is positive given robust AI-driven growth prospects and strong execution. However, investors should monitor margin pressures from the low 2.9% net income margin and negative cash flow trends. The stock's elevated P/E ratio of 30.14 requires sustained earnings growth to justify current valuations amid competitive pressures in electronics manufacturing.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Indivior Pharmaceuticals Inc. Common Stock
Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.
Read more on INDV →About Jabil Inc
Jabil is a global manufacturing solutions provider for industries including healthcare, automotive, and cloud. It offers comprehensive design, engineering, and supply chain management for complex electronic products.
Read more on JBL →
